Overview

Drug-durg Interaction of ZSP1273 With Digoxin, Rosuvastatin,Itraconazole and Probenecid

Status:
Completed
Trial end date:
2023-11-30
Target enrollment:
Participant gender:
Summary
The drug-drug interaction study had been designed to investigate the effect of ZSP1273 on the pharmacokinetics of digoxin, Rosuvastatin and the effect of Itraconazole and Probenecid on the pharmacokinetics of ZSP1273
Phase:
Phase 1
Details
Lead Sponsor:
Guangdong Raynovent Biotech Co., Ltd
Treatments:
Digoxin
Itraconazole
Probenecid
Rosuvastatin Calcium